Incorporation of Rapid Thermodynamic Data in Fragment-Based Drug Discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incorporation of Rapid Thermodynamic Data in Fragment-Based Drug Discovery

Published:2013-02-27 Issue:5 Volume:56 Page:2155-2159
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kobe Akihiro¹²,Caaveiro Jose M. M.¹²,Tashiro Shinya²,Kajihara Daisuke³,Kikkawa Masato³,Mitani Tomoya³,Tsumoto Kouhei¹²⁴

Affiliation:

1. Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan

2. Department of Medical Genome Science, School of Frontier Sciences, The University of Tokyo, Kashiwa 277-8562, Japan

3. Life Science Division, GE Healthcare Japan, 3-25-1 Hyakuninicho, Shinjuku, Tokyo 169-0073, Japan

4. Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, Tokyo 113-8656, Japan

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm301603n

Reference28 articles.

1. Diagnosing the decline in pharmaceutical R&D efficiency

2. Discovering High-Affinity Ligands for Proteins: SAR by NMR

3. Fragment-Based Drug Discovery

4. A decade of fragment-based drug design: strategic advances and lessons learned

5. The rise of fragment-based drug discovery

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ensemble-function relationships to dissect mechanisms of enzyme catalysis;Science Advances;2022-10-14

2. Ensemble–function relationships to evaluate catalysis in the ketosteroid isomerase oxyanion hole;2021-09-30

3. Lipid nanodiscs facilitate the identification of a fragment compound inhibiting the enzymatic activity of the bacterial membrane protein MsbA;2021-06-16

4. Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors;Journal of Medicinal Chemistry;2021-02-23

5. Using NMR Spectroscopy in the Fragment‐Based Drug Discovery of Small‐Molecule Anticancer Targeted Therapies;ChemMedChem;2020-12-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3